NLRP3 and Parkinson disease: If this synergy is disrupted such that the dopamine supply is depleted and NLRP3 inflammasome activation intensifies, the three major facets of PD pathology (α-syn accumulation, neuroinflammation, and dopaminergic neurodegeneration) would be augmented as a result of weakened microglial regulation.